SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-213662
Filing Date
2021-07-13
Accepted
2021-07-13 08:52:59
Documents
4
Period of Report
2021-07-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d200455d8k.htm 8-K 18146
2 EX-99.1 d200455dex991.htm EX-99.1 23016
3 GRAPHIC g200455g73e92.jpg GRAPHIC 4999
4 GRAPHIC g200455g87c21.jpg GRAPHIC 19970
  Complete submission text file 0001193125-21-213662.txt   76983
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 211086872
SIC: 2836 Biological Products, (No Diagnostic Substances)